Effect of Intracuff Alkalinized Lidocaine on Coughing Incidence at Extubation
- Conditions
- CoughingLidocaineEndotracheal CuffExtubation
- Interventions
- Procedure: Endotracheal intubation with injection of liquid in the cuff
- Registration Number
- NCT01774292
- Lead Sponsor
- Université de Sherbrooke
- Brief Summary
The purpose of the study is to determined whether the administration of alkalized 4% lidocaine (160 mg) in the endotracheal tube cuff is effective in diminishing the incidence of coughing at extubation in surgeries lasting more than 2 hours without the use of nitrous oxide as an anesthetic agent.
- Detailed Description
The diffusion of nitrous oxide inside the endotracheal cuff leads to increase pressure, pain and coughing. Studies have shown benefit of alkalized lidocaine and other mediums within the cuff with nitrous oxide. No study has yet evaluated the benefit of alkalized lidocaine in long surgeries without the use of nitrous oxide.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 80
- ASA 1,2 or 3 patients requiring general anesthesia for an elective urological or gynecological surgery predicted to last more than 2 hours
- Patient refusal
- Lidocaine allergy
- Any allergies to drugs or anesthetics used during the study
- Under 18 years of age
- Pregnant
- Previous airway surgery
- Cormack 3 or 4 or anticipated difficult airway
- Upper respiratory tract infection in the last month
- Active respiratory disease
- Chronic cough or throat pain
- Gastro-esophageal reflux disease or at risk for aspiration
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Alkalized lidocaine Endotracheal intubation with injection of liquid in the cuff 160 mg of 4% lidocaine (4 ml) in the endotracheal cuff and add bicarbonate 8,4% until appropriate seal. Sterile saline Endotracheal intubation with injection of liquid in the cuff 4 mL of sterile saline in the endotracheal cuff and add bicarbonate 8,4% until appropriate seal.
- Primary Outcome Measures
Name Time Method Coughing 24 hours after the end ofsurgery
- Secondary Outcome Measures
Name Time Method Nausea and Vomiting 24 hours after end of surgery Throat pain 24 hours after the end of surgery Hoarseness of the voice 24 hours after end of surgery
Trial Locations
- Locations (1)
Centre Hospitalier Universitaire de Sherbrooke
🇨🇦Sherbrooke, Quebec, Canada